ES2188940T3 - Administracion topica de premafloxacina para el tratamiento de enfermedades bacterianas sistemicas. - Google Patents
Administracion topica de premafloxacina para el tratamiento de enfermedades bacterianas sistemicas.Info
- Publication number
- ES2188940T3 ES2188940T3 ES97921434T ES97921434T ES2188940T3 ES 2188940 T3 ES2188940 T3 ES 2188940T3 ES 97921434 T ES97921434 T ES 97921434T ES 97921434 T ES97921434 T ES 97921434T ES 2188940 T3 ES2188940 T3 ES 2188940T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- topma
- premaphloxacine
- administration
- bacterial diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Processing Of Solid Wastes (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA UN PROCEDIMIENTO PARA ADMINISTRAR DE MANERA TOPICA AGENTES ANTIMICROBIANOS, COMO PREMAFLOXACINA, COMPUESTO EN FORMA DE PREMAFLOXACINA, ESTER DE PREMAFLOXACINA, CIPROFLOXACINA, ENROFLOXACINA, CEFQUINON, CEFPODOXIN, GENTAMICINA O ERITROMICINA, PARA EL TRATAMIENTO DE ENFERMEDADES BACTERIANAS QUE AFECTAN A TODO EL CUERPO, EN MAMIFEROS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64409196A | 1996-05-10 | 1996-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2188940T3 true ES2188940T3 (es) | 2003-07-01 |
Family
ID=24583416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97921434T Expired - Lifetime ES2188940T3 (es) | 1996-05-10 | 1997-05-05 | Administracion topica de premafloxacina para el tratamiento de enfermedades bacterianas sistemicas. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0898477B1 (es) |
JP (1) | JP2000510842A (es) |
AT (1) | ATE229805T1 (es) |
AU (1) | AU721819B2 (es) |
DE (1) | DE69717988T2 (es) |
DK (1) | DK0898477T3 (es) |
ES (1) | ES2188940T3 (es) |
NZ (2) | NZ332719A (es) |
TW (1) | TW477707B (es) |
WO (1) | WO1997042954A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999013053A1 (en) | 1997-09-10 | 1999-03-18 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
US6080849A (en) | 1997-09-10 | 2000-06-27 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
ID21415A (id) * | 1997-12-05 | 1999-06-10 | Upjohn Co | Senyawa-senyawa antibiotik magnesium quinolon |
MY122454A (en) * | 1998-06-05 | 2006-04-29 | Upjohn Co | Use of oxazolidinones for the preparation of a medicament for transdermal delivery |
WO2000053594A1 (fr) | 1999-03-10 | 2000-09-14 | Daiichi Pharmaceutical Co., Ltd. | Derives aminomethylpyrrolidine possedant des substituants aromatiques |
US6962696B1 (en) | 1999-10-04 | 2005-11-08 | Vion Pharmaceuticals Inc. | Compositions and methods for tumor-targeted delivery of effector molecules |
DE102004001558A1 (de) * | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
EP2059231A1 (en) * | 2006-08-30 | 2009-05-20 | Intervet International BV | Pharmaceutical compositions comprising cefquinome |
CA2671938C (en) * | 2006-12-10 | 2017-10-17 | Chongxi Yu | Transdermal delivery systems of beta-lactam antibiotics |
US9969751B2 (en) | 2009-06-10 | 2018-05-15 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
RU2586287C2 (ru) * | 2009-06-10 | 2016-06-10 | Текфилдз Байокем Ко., Лтд. | Композиции или пролекарства противомикробных и родственных противомикробным соединений, обладающие высокой проникающей способностью |
CA3189252A1 (en) | 2012-05-16 | 2013-11-21 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions |
JP5795343B2 (ja) * | 2013-01-23 | 2015-10-14 | チョンシー ユー | β−ラクタム抗生物質の経皮送達システム |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3743727A (en) * | 1970-11-16 | 1973-07-03 | Crown Zellerbach Corp | Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide |
US4507287A (en) * | 1983-06-20 | 1985-03-26 | Dixon Glen J | Preparation and method for the treatment of acne |
US4557934A (en) * | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
CA2095338C (en) * | 1990-11-30 | 2002-04-09 | John Michael Domagala | Individual stereoisomers of 7-¬3-(aminoalkyl)-1-pyrrolidinyl|-quinolonesand naphthyridones as antibacterial agents |
CN1081103A (zh) * | 1992-09-19 | 1994-01-26 | 蒋明威 | 含喹诺酮类药物的透皮制剂及其制备方法 |
-
1997
- 1997-05-05 AT AT97921434T patent/ATE229805T1/de not_active IP Right Cessation
- 1997-05-05 AU AU27470/97A patent/AU721819B2/en not_active Ceased
- 1997-05-05 EP EP97921434A patent/EP0898477B1/en not_active Expired - Lifetime
- 1997-05-05 TW TW086105947A patent/TW477707B/zh not_active IP Right Cessation
- 1997-05-05 ES ES97921434T patent/ES2188940T3/es not_active Expired - Lifetime
- 1997-05-05 NZ NZ332719A patent/NZ332719A/xx unknown
- 1997-05-05 DK DK97921434T patent/DK0898477T3/da active
- 1997-05-05 JP JP09540887A patent/JP2000510842A/ja not_active Withdrawn
- 1997-05-05 NZ NZ336873A patent/NZ336873A/en unknown
- 1997-05-05 WO PCT/US1997/007124 patent/WO1997042954A1/en active IP Right Grant
- 1997-05-05 DE DE69717988T patent/DE69717988T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK0898477T3 (da) | 2003-03-24 |
TW477707B (en) | 2002-03-01 |
EP0898477B1 (en) | 2002-12-18 |
DE69717988T2 (de) | 2003-07-24 |
WO1997042954A1 (en) | 1997-11-20 |
NZ332719A (en) | 2000-01-28 |
NZ336873A (en) | 2001-02-23 |
AU2747097A (en) | 1997-12-05 |
DE69717988D1 (de) | 2003-01-30 |
JP2000510842A (ja) | 2000-08-22 |
AU721819B2 (en) | 2000-07-13 |
ATE229805T1 (de) | 2003-01-15 |
EP0898477A1 (en) | 1999-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188940T3 (es) | Administracion topica de premafloxacina para el tratamiento de enfermedades bacterianas sistemicas. | |
TR199901127T2 (xx) | Antibakteriyel etkili 6-O-ikameli ketolitler. | |
BR9710768A (pt) | Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i | |
AU6339599A (en) | Quinoline derivatives and their use as antibacterial agents | |
PT806941E (pt) | Composicoes anti-bacterianas liposomicas de rigidez baixa | |
WO2000044761A3 (en) | Ketolide antibiotics | |
BG104644A (en) | Novel macrolides | |
WO2002006301A3 (en) | Peptides with antioxidant and antimicrobial properties | |
AU4170197A (en) | Pharmaceutical compounds | |
DK1434779T3 (da) | Tværbundne glycopeptid-cephalosporinantibiotika | |
AU2003231833A1 (en) | Cross-linked glycopeptide-cephalosporin antibiotics | |
PE20011188A1 (es) | El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos | |
DK1007530T3 (da) | 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf | |
AR025379A1 (es) | 9a-azalidas con actividad antibacteriana. | |
ES2173586T3 (es) | Derivados de ciclohexandiol. | |
AU9067198A (en) | Proton pump inhibitor in therapeutic combination with antibacterial substances | |
NO20042711L (no) | Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum | |
ES2184121T3 (es) | Formulacion para el tratamiento y/o profilaxis de la demencia. | |
HUP0004616A2 (hu) | Tetrahidrofurán-származék hidroxi-észtere mint gombaellenes szer prodrogja | |
ECSP961832A (es) | Polimorfos del profarmaco de 6-n-( l-ala-l-ala)- trovafloxacina | |
UA30359A (uk) | Спосіб лікування гнійних ран |